Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Risk factors of delirium in paediatric intensive care units: A meta-analysis

Abstract

Background

Delirium is a brain dysfunction syndrome, which children have a higher incidence. At present, there have been more and more studies and reports on delirium in paediatric intensive care unit, but there are some differences in the risk factor results among different studies. To better manage delirium, this study was performed.

Objective

To integrate and clarify the risk factors for delirium in paediatric intensive care unit.

Methods

CNKI, CBMdisc, Wanfang Data Knowledge Service Platform, VIP, PubMed, Embase, Cochrane Library, JBI and PsycInfo were searched for relevant literature. The study subjects were patients in PICU and literature was included according to the PICOS principle. Literature screening and risk of bias assessment were mainly completed by two researchers, and RevMan 5.3 software and Stata software were used for data analysis. The GRADE systerm was used to assess the quality of evidence.

Results

A total of 10 studies were included, all in English, involving 4343 children. Within the GRADE system, 4 indicators were scored A, 1 indicators were scored B, and 3 indicators were scored C regarding evidence levels. Three studies analysed the influence of developmental delay on the occurrence of delirium in PICU, total sample size of which was 1823, and the results showed that the combined effect was statistically significant [OR = 3.34, 95%CI(2.46–4.53), Z = 7.75, P<0.001]; Five studies analysed the effects of mechanical ventilation on the occurrence of delirium in PICU, sample size of which was 1562, and the results showed that the combined effect was statistically significant [OR = 4.11, 95%CI(3.13–5.40), Z = 10.16, P<0.001]; Two studies analysed the effects of benzodiazepines on children developing delirium, sample size of which was 1635, and the results showed that the combined effect was statistically significant [OR = 5.05, 95%CI(3.65–6.97), Z = 9.83, P<0.001]; Two studies analysed the effects of anticholinergic drug use on children developing delirium in PICU, sample size of which was 1703, and the results suggested the combined effect was statistically significant [OR = 5.04, 95%CI (3.62–7.00), Z = 9.63, P<0.001]; Two studies compared the same age period, sample size of which was 1724 and the results showed that children 2–5 years old has a 48% incidence rate of delirium relative to children younger than 2 years old, and the combined effect was statistically significant [OR = 0.48, 95%CI(0.25–0.92), Z = 2.22, P = 0.030], children 5–13 years old has a 39% incidence rate of delirium relative to children younger than 2 years old, and the combined effect was statistically significant [OR = 0.39, 95%CI(0.26–0.59), Z = 4.43, P<0.001]. Two studies analysed the effects of PICU LOS on children developing delirium and the combined effect of PICU LOS on the occurrence of delirium in children in PICU was statistically significant [OR = 1.10, 95%CI(1.05–1.15), Z = 4.07, P<0.001].

Conclusion

Developmental delay, mechanical ventilation, benzodiazepine use, anticholinergic use, age and PICU length of stay are independent risk factors for delirium in children in PICU. However, only a few articles were included in this study, which may lead to a certain bias and affect the analysing results. More large-sample, multicentre studies should be conducted to further explore and clarify the independent influencing factors of delirium in children in PICU and to provide guidance for clinical practice.

1 Introduction

1.1 Overview and research significance

Delirium is a brain disorder characterised by acute cognitive and arousal changes [1, 2] with a slow reaction, continuous excited movement, and emotional instability or insecurity as the main manifestations [3]. Children have a high incidence of delirium. In one study [4], a delirium rate of 69% was found in patients with a length of stay > 48 hrs (37% of the total sample). Delirium in children leads to adverse outcomes, such as complications, falls, prolonged hospital stay, and prolonged mechanical ventilation and even death [5, 6]. Delirium also makes it more likely that the child’s cognitive, emotional, and social abilities were impaired after discharge, which makes the caregivers suffering [2, 4, 7]. Traube et al. revealed that the medical expenses of children with delirium were almost four times those of children without delirium in the paediatric intensive care unit (PICU) [8]. At present, there is an increasing number of reports on paediatric delirium, but there are some differences in the results regarding risk factors across studies, and the cases are relatively scattered. To better manage delirium in the paediatric population, related studies on risk factors for delirium in children were reviewed, and through meta-analysis, influencing factors were evaluated. The final goal is to help clinical staff identify risk factors for delirium, screen high-risk children, and provide a timely reference for prevention and prognosis improvement.

1.2 Diagnosis or screening of delirium

To judge delirium, psychiatrists and clinicians can refer to the Diagnostic and Statistical Manual of Mental Disorders (DSM) [9], the gold standard for diagnosis. Additionally, some brief and valid screening tools have emerged for use in recent years, such as the Cornell Assessment of Paediatric Delirium (CAPD), the Sophia Observation Withdrawal Symptoms Paediatric Delirium (SOS-PD) scale, the Paediatric Confusion Assessment Method for the ICU (pCAM-ICU), and the Preschool Confusion Assessment Method for the ICU (psCAM-ICU). However, suitable subjects of these tools have some differences. The CAPD is used to detect delirium in PICU settings and consists of eight items. It has a sensitivity of 94.1% (95% confidence interval [CI]: 83.8–98.8%), a specificity of 79.2% (95% CI: 73.5–84.9%), and Cronbach’s α of 0.90 [10]. The pCAM-ICU, a cognitive tool requiring patient cooperation, is restricted to children older than 5, limited to patients with developmental delay, and requires extensive nurse training. The pCAM-ICU assesses fluctuations in mental status, attention, altered levels of consciousness, and disorganised thinking and has been validated with a sensitivity of 0.83 and a specificity of 0.99 in critically ill children aged 5 and older [11]. The PD-scale of the SOS-PD scale consists of 17 items used for early screening of PD in critically ill children. It has an overall sensitivity of 92.3% and a specificity of 96.5% compared to the psychiatrist’s diagnosis for a cut-off score ≥ 4 points. The Pearson coefficient between the PD scale and the CAPD is 0.89% (95% CI: 0.82–0.93). The intraclass correlation coefficient is 0.90 (95% CI: 82.7–99.4) [12]. The psCAM-ICU is a highly valid, reliable delirium instrument for critically ill infants and preschool-aged children, demonstrating a specificity of 91% (95% CI: 90–93), a sensitivity of 75% (95% CI: 72–78), a negative predictive value of 86% (95% CI: 84–88), a positive predictive value of 84% (95% CI: 81–87), and a reliability κ–statistic of 0.79 (0.76–0.83) [13].

1.3 Research status and progress regarding the risk factors for delirium in children

Due to a late start, research on the risk factors for delirium in critically ill children is limited. Univariate analyses comprise the majority of studies, while there is little research based on multivariable logistic regression analysis of delirium risk factors. The risk factors included in these studies and the results of the same risk factors vary. There is controversy, and the risk factors remain unclear. The existing research on the risk factors for paediatric delirium is still incomplete.

1.4 The pathophysiology of delirium

The causes and mechanism of delirium are complex and have not yet been elucidated. It has been hypothesised that systemic inflammation may lead to damage to blood-brain barrier integrity or the production of inflammatory products in the brain, giving rise to ischaemia and neuronal apoptosis [14]. The most common pathways associated with delirium development include acetylcholine and/or melatonin deficiencies; the overrelease of dopamine, norepinephrine and/or glutamic acid; and changes in 5-hydroxytryptamine [15, 16]. The level of neurotransmitters in the brain shifts in response to physiological stressors. Ultimately, brain decompensation or chemical changes cannot be controlled [17].

2 Materials and methods

We registered the meta-analysis on Prospero; the ID number is CRD4202020208219.

2.1 Inclusion and exclusion criteria

2.1.1 Inclusion criteria.

According to the PICOS principle:

  1. P (patient or population): Patients in PICUs, which are hospital units providing continuous surveillance and care to acutely ill infants and children.
  2. I/E (intervention/exposure): Exposure includes physiological factors, therapeutic factors, drug factors, age factors, and other susceptibility factors.
  3. C (comparison/control): Individuals not exposed to some susceptibility factors above.
  4. O (outcome): Delirium, which means a disorder characterised by confusion, inattentiveness, disorientation, illusions, hallucinations, and agitation.
  5. S (study design): Three research types include case-control studies, cohort studies, and cross-sectional studies. Raw data in the literature provide odds ratios (ORs) or relative ratios (RRs) and 95% CIs, or can obtain data-converted OR values and 95% CIs.

2.1.2 Exclusion criteria.

① The study was a duplicate publication; and ② the original research is inaccessible in a variety of ways.

2.2 Literature retrieval strategy

We developed a literature search strategy. The search words were ‘Child */Paediatric */Paediatric */PICU/P*ediatric Intensive Care Unit’, ‘Delirium’, ‘Risk factor*/Relative factor*/risk*/Relative risk*/Influencing factor*’, and ‘Case–Control stud*/Cohort Stud*/Cross-sectional stud*/Observational Stud*’. We combined Boolean logic operators, major topic terms, and free words to search the China National Knowledge Infrastructure (CNKI), China Biology Medicine Disc (CBMdisc), the Wanfang Data Knowledge Service Platform, the China Science and Technology Journal Database (VIP), PubMed, Embase, Cochrane Library, Joanna Briggs Institute (JBI), and PsycInfo. We set the article publication time range as of September 2021. We browsed the references included in the retrieved literature and were prepared to carry out a secondary search if necessary.

2.3 Literature screening and quality evaluation

After downloading the titles, two researchers preliminarily eliminated duplicate studies, studies with inappropriate research content or methods, or subjects or types by looking at the titles and abstracts. Then, we downloaded the full texts of the remaining studies and read them carefully, excluding studies in which the full texts were inaccessible or did not meet the screening criteria. Two researchers assessed the quality of the full texts by referring to the Newcastle–Ottawa Scale (NOS). We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, an approach to judge the quality of evidence and strength of recommendations, to evaluate the quality of evidence for outcome measures. When disagreement appeared between the two researchers, other researchers in the group participated in the evaluation to determine the quality of the studies or evidence together. Any difference was discussed in the group until consensus was reached.

2.4 Statistical methods

We extracted the data from the original study and analysed them via RevMan 5.3 and Stata 15.0 software. We examined heterogeneity among the studies using the Cochrane Q test. If P ≥ 0.1 and I2 ≤ 50%, we considered there to be homogeneity among the studies, and we could use a fixed effects model; otherwise, the source of heterogeneity could be identified as much as possible through sensitivity analysis. If heterogeneity could not be eliminated, we adopted a random effects model, and used descriptive analysis if the heterogeneity was too large and the source could not be determined. Value variable data are shown by weighted mean difference (WMD) and 95% CI. Dicategorised variable data are presented in the form of ORs and 95% CIs. We used Egger’s test to check for publication bias.

3 Results

3.1 Literature retrieval results

We initially searched a total of 270 studies, including 81 in Chinese and 189 in English. We screened out 51 duplicate studies and excluded 192 by reading the titles and abstracts due to unmatched research subjects or content or types; we initially included 27 studies. After further reading, we excluded 17 studies and finally included 10, all in English, encompassing a total of 4,343 patients (Fig 1).

3.2 Basic characteristics and methodological quality evaluation of the included studies (Tables 13)

thumbnail
Table 3. Assessment of evidence level based on GRADE system.

https://doi.org/10.1371/journal.pone.0270639.t003

We included nine cohort studies and one case–control study, all published in the last 5 years. The subjects were children and adolescents not more than 21 years old, and all were from the PICU. The number of patients in each study ranged from 99 to 1,547. The risk factors included in the studies are displayed in Table 1. We performed quality evaluation based on the NOS and NOS total scores of the studies, all marked with 5 to 8 stars (Table 2). Within the GRADE system, 4 indicators were scored A, 1 indicator was scored B, and 3 indicators were scored C regarding evidence levels (Table 3).

3.3 Meta-analysis results

3.3.1 The effects of developmental delay on PICU delirium.

Three articles included in this study examined the effects of developmental delay on the occurrence of delirium in children [18, 19, 24]. We did not detect obvious heterogeneity (I2 = 0%, P = 1.000), and we used a random effects model due to the potential heterogeneity among the studies. The combined effect was statistically significant [OR = 3.34, 95% CI (2.46–4.53), Z = 7.75, P<0.001], suggesting that developmental delay is an independent influencing factor for the occurrence of paediatric delirium (Fig 2). Publication bias was not apparent according to Egger’s test outcomes [t = 1.540, P = 0.366].

thumbnail
Fig 2. Forest plot for developmental delay analysis.

We conducted meta-analysis for 3 studies using a random effect model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g002

3.3.2 The effects of mechanical ventilation on PICU delirium.

The effects of mechanical ventilation on paediatric delirium were discussed in seven articles [1822, 24, 25]. The heterogeneity test suggested strong heterogeneity among the selected studies (I2 = 77%, P<0.001); the heterogeneity was still strong when we used a random effects model. Therefore, we employed sensitivity analysis to further explore the source of heterogeneity. After removing the selected studies one by one, the studies of Traube C 2017 [19] and Traube C 2017(1) [24] were the main sources of heterogeneity, as they have the same first author and have a similar influence on the combined effect. We carried out descriptive analysis for 2 studies, and meta-analysis for 5 studies using a random effects model, with no obvious heterogeneity (I2 = 9%, P = 0.360) [OR = 4.11, 95% CI (3.13–5.40), Z = 10.16, P<0.0000] (Fig 3). We determined mechanical ventilation to be an independent risk factor for delirium in children. Traube C [19] showed that mechanical ventilation is an independent risk factor for delirium. Another study by Traube C [24] revealed the same conclusion. Publication bias was not apparent [t = 2.090, P = 0.104].

thumbnail
Fig 3. Forest plot for mechanical ventilation analysis.

We conducted meta-analysis for 5 studies using a random effect model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g003

3.3.3 The effects of benzodiazepine use on PICU delirium.

Three articles [1921] examined the influence of benzodiazepines on children developing delirium. The analysis indicated that the heterogeneity among the studies was strong (I2 = 86%, P = 0.001). We removed the articles one by one and found that the main source of heterogeneity may have been Mody K 2018 [21], in which the considered factor was benzodiazepine exposure on the previous day, which was different from other studies on benzodiazepine exposure. After deletion, we performed meta-analysis for the remaining 2 articles, which demonstrated no obvious heterogeneity (I2 = 0%, P = 0.520); thus, we used a random effects model for analysis. The results signalled that benzodiazepine use is an independent risk factor for the occurrence of paediatric delirium, and the combined effect was statistically significant [OR = 5.05, 95% CI (3.65–6.97), Z = 9.83, P<0.001] (Fig 4). Mody K [21] illustrated that benzodiazepine use is closely associated with the transition from normal cognitive status to delirium, with a more than fourfold increase in the delirium occurrence rate.

thumbnail
Fig 4. Forest plot for benzodiazepine use analysis.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g004

3.3.4 The effects of anticholinergic drug use on PICU delirium.

We included two articles [19, 20] to observe the effects of anticholinergic drugs on the occurrence of childhood delirium. The heterogeneity test revealed no significant heterogeneity (I2 = 0%, P = 0.420), and we used a random effects model for analysis. The results imply that the combined effect of the independent risk factors regarding the occurrence of delirium in children treated with anticholinergic drugs is statistically significant [OR = 5.04, 95% CI (3.62–7.00), Z = 9.63, P<0.001] (Fig 5). Because we only included two articles in the analysis, we could not employ Egger’s test to detect publication bias, as doing so would have been meaningless.

thumbnail
Fig 5. Forest plot for anticholinergic drug use analysis.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g005

3.3.5 The effects of age on PICU delirium.

The effects of age on the occurrence of paediatric delirium were examined in 6 articles [1820, 23, 24]. We used descriptive analysis for 3 articles of different age groups, and we performed a meta-analysis for the remaining 3 articles [18, 19, 23]. We noted significant heterogeneity via a heterogeneity test (I2 = 85%, P<0.001) in the analysis between children aged 0 to 2 and children aged 2 to 5 among 3 articles. We used sensitivity analysis to scrutinise the sources of heterogeneity; the main source of heterogeneity might be found in the work of Silver G [18], as the number of cases was relatively small. After removing four studies, we compared children aged 0 to 2 with those aged 2 to 5, 5 to 13, and > 13 in the remaining 2 studies to identify the effects of age on paediatric delirium. These comparisons showed low heterogeneity, no obvious heterogeneity, and significant heterogeneity (I2 = 49%, P = 0.160; I2 = 0%, P = 0.590; I2 = 88%, P = 0.004); thus, we used a random effects model for analysis. Children aged 2 to 5 had a 48% incidence rate of delirium relative to children younger than 2, and the combined effect was statistically significant [OR = 0.48, 95% CI (0.25–0.92), Z = 2.22, P = 0.030]. Children aged 5 to 13 years old had a 39% incidence rate of delirium relative to children younger than 2, and the combined effect was statistically significant [OR = 0.39, 95% CI (0.26–0.59), Z = 4.43, P<0.001]. The children (>13 years old) and (<2 years old) displayed no significant difference [Z = 1.89, P = 0.060] (Figs 68). Alvarez RV [20] revealed that age is an independent risk factor for delirium and indicated that the probability of delirium decreases by 65% with each additional month of age. In addition, Traube C(1) [24] demonstrated that age (> 2 years old) is an independent, protective factor against delirium.

thumbnail
Fig 6. Forest plot for ages between 0 to 2 and 2 to 5.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g006

thumbnail
Fig 7. Forest plot for ages between 0 to 2 and 5 to 13.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g007

thumbnail
Fig 8. Forest plot for ages between 0 to 2 and > 13.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g008

3.3.6 The effects of PICU LOS on PICU delirium.

We included two articles [25, 26] to observe the effects of PICU LOS on the occurrence of childhood delirium. The heterogeneity test indicated no significant heterogeneity (I2 = 0%, P = 0.420), and we used a random effects model for analysis. The combined effect of PICU LOS on the occurrence of delirium in children in the PICU was statistically significant [OR = 1.10, 95% CI (1.05–1.15), Z = 4.07, P<0.001] (Fig 9).

thumbnail
Fig 9. Forest plot for PICU LOS analysis.

We conducted meta-analysis for 2 studies using a random effects model. We used ORs and 95% CIs to represent the results.

https://doi.org/10.1371/journal.pone.0270639.g009

4 Discussion

4.1 Methodological quality evaluation of the included literature

The number of studies included in the analysis was relatively small. All 10 studies were above 5 stars for NOS scores. The evidence levels of the study indicators were medium or high. The study indicators were relatively concentrated, and the meta-analysis showed good intergroup homogeneity. The subject sources and the inclusion and exclusion criteria were all clear.

4.2 Main findings and implications for clinical practice

The possible factors for the incidence of delirium in children were developmental delay, mechanical ventilation, benzodiazepine use, anticholinergic drug use, and age. The systematic review performed by Holly C et al. [28] revealed that young age, male sex, developmental delay, mechanical ventilation, and anxiety factors contribute to a higher likelihood of developing delirium, which is partly consistent with our results. The ORs and 95% CIs were not part of the work of Dervan LA et al. [29]; therefore, we did not include them in this study. This result suggests that delirium is independently correlated with age (< 2 years old) and mechanical ventilation, corresponding to our findings. This study can guide healthcare providers to address particular aspects, enhance their understanding of paediatric delirium, and help them to prevent delirium. We found that children with developmental delay are 3.34 times more likely to develop delirium than those with normal development. The probability of delirium in children on mechanical ventilation is 4.11 times higher than in children without mechanical ventilation. Children who have used benzodiazepines have a 5.05 times greater risk of delirium than those who do not, and children who use anticholinergic drugs are 5.04 times more likely to develop delirium than those who do not. Age and PICU length of stay are also independent risk factors for delirium. Hence, healthcare providers should pay more attention to children with developmental delay and conduct interventions to promote their growth processes. For children on mechanical ventilation, indications for machine withdrawal should be evaluated daily, and basic care should be well maintained to help children get offline as soon as possible. Benzodiazepine and anticholinergic drug use need to be balanced. Common PICU anticholinergic drug were all low-level, with midazolam (the most common) in the highest anticholinergic drug scale scores (95%), followed by vancomycin(81%), piperacillin (79%), and morphine (74%) [30]. Alternative drugs should be considered in patients requiring large amounts of anticholinergic burden drugs, and further screening and assessment should be made using validated scales for anticholinergic exposure [31]. Children younger than 2 years old also need attention. Under the premise of ensuring safety, the time spent in the PICU is reduced as much as possible. By strengthening the management of delirium risk factors, the occurrence of delirium can be mitigated. Timely reporting and appropriate interventions are critical.

4.3 Limitations

There was a small number of included studies, mainly carried out in European and American countries, which may lead to a certain bias in the analysis and affect the results.

4.4 Future outlook

This study suggests that healthcare providers need to strengthen the identification of risk factors and actively draw up care plans based on the above factors and implement them. However, challenges include variable delirium symptoms, a lack of specialised training, and low compliance rates for performing assessments [17]. According to a survey [32], although delirium is common in critically ill children, only 2% of PICUs screen for delirium. As such, it is significant to develop an appropriate delirium evaluation procedure or criterion [7]. A previous study [33] found that nurses in the PICU lacked an understanding of risk factors. In another study, 42 PICU nurses were trained, and knowledge of and attitudes toward delirium were significantly improved after training [26]. Nurses play an important role in helping with the prevention and care of delirium. It is necessary to do some training. The training content can involve the diagnosis, evaluation and identification of delirium, adverse consequences, and risk factors. For the prevention and treatment of delirium, non-pharmacological interventions such as music therapy, massage, avoidance of acousto-optic stimulation, exercise, and family participation should be emphasised [4].

5 Conclusion

Paediatric delirium has a high incidence rate; hence, there is a need to explore the risk factors for delirium and to strengthen the screening of delirium by improving clinical staff cognition to effectively prevent delirium. We found that developmental delay, mechanical ventilation, benzodiazepine use, anticholinergic use, age, and PICU length of stay are independent risk factors for delirium in paediatrics. However, we only included a few studies in this meta-analysis, which may have resulted in a certain degree of publication bias. Consequently, more large-sample, multicentre studies should be conducted to further explore and clarify the independent influencing factors of delirium in paediatrics and to provide guidance for clinical practice.

Supporting information

S1 Table. Checklist of items to include when reporting a systematic review or meta-analysis.

https://doi.org/10.1371/journal.pone.0270639.s001

(DOCX)

References

  1. 1. Silver GH, Kearney JA, Bora S, De Souza C, Giles L, Hrycko S, et al. A clinical pathway to standardize care of children with delirium in pediatric inpatient settings. Hosp Pediatr. 2019; 9(11): 909–916. pmid:31662421
  2. 2. NICE. Risk reduction and management of delirium: A national clinical guideline, 2019: 1–46.
  3. 3. Smith HA, Brink E, Fuchs DC, Ely EW, Pandharipande PP. Pediatric delirium:monitoring and management in the pediatric intensive care unit. Pediatr Clin North Am. 2013; 60(3): 741–760. pmid:23639666
  4. 4. Ista E, van Dijk M. High incidence of pediatric delirium in PICU: time for action!. Pediatr Crit Care Med. 2020; 21(1): 96–97.
  5. 5. Paterson RS, Kenardy JA, Dow BL, De Young AC, Pearson K, Aitken LM. Accuracy of delirium assessments in critically ill children: A prospective, observational study during routine care. Aust Crit Care. 2021; 34(3): 226–234. pmid:33909556
  6. 6. Kupferschmid M, Tripathi S. Utilization of Kotter’s stages and statistical process control to implement and sustain delirium screening in PICU. Pediatr Qual Saf. 2021; 6(6):1–9. pmid:34901682
  7. 7. Wei WR, Ge XH, Zheng QR. Research progress on management of delirium in children in ICU. Chinese journal of nursing management. 2019; 19(8): 1238–1243.
  8. 8. Traube C, Mauer EA, Gerber LM, Kaur S, Joyce C, Kerson A, et al. Cost associated with pediatric delirium in the ICU. Crit Care Med. 2016; 44(12): e1175–e1179. pmid:27518377
  9. 9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders[M]. 5th ed. Washington: APA Publishing, 2013.
  10. 10. Traube C, Silver G, Kearney J, Patel A, Atkinson TM, Yoon MJ, et al. Cornell assessment of pediatric delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med. 2014; 42(3): 656–663. pmid:24145848
  11. 11. Rohlik GM, Fryer KR, Tripathi S, Duncan JM, Coon HL, Padhya DR, et al. Overcoming barriers to delirium screening in the pediatric intensive care unit. Crit Care Nurse. 2018; 38(4): 57–67. pmid:30068721
  12. 12. Ista E, van Beusekom B, van Rosmalen J, Kneyber MCJ, Lemson J, Brouwers A, et al. Validation of the SOS-PD scale for assessment of pediatric delirium: a multicenter study. Crit Care. 2018; 22(1): 1–12.
  13. 13. Smith HA, Gangopadhyay M, Goben CM, Jacobowski NL, Chestnut MH, Savage S, et al. The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically ill infants and children. Crit Care Med. 2016; 44(3): 592–600. pmid:26565631
  14. 14. Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013; 21(12): 1190–222. pmid:24206937
  15. 15. Smith HA, Berutti T, Brink E, Strohler B, Fuchs DC, Ely EW, et al. Pediatric critical care perceptions on analgesia, sedation, and delirium. Semin Resp Crit Care Med. 2013; 34(2): 244–261.
  16. 16. Maldonado JR. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium. Crit Care Clin. 2017; 33(3): 461–519. pmid:28601132
  17. 17. Mulkey MA, Hardin SR, Olson DM, Munro CL. Pathophysiology review: seven neurotransmitters associated with delirium. Clin Nurse Spec. 2018; 32(4): 195–211. pmid:29878931
  18. 18. Silver G, Traube C, Gerber LM, Sun X, Kearney J, Patel A, et al. Pediatric delirium and associated risk factors: a single-center prospective observational study. Pediatr Crit Care Med. 2015; 16(4): 303–309. pmid:25647240
  19. 19. Traube C, Silver G, Gerber LM, Kaur S, Mauer EA, Kerson A, et al. Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium. Crit. Care Med. 2017; 45(5): 891–898. pmid:28288026
  20. 20. Alvarez RV, Palmer C, Czaja AS, Peyton C, Silver G, Traube C, et al. Delirium is a common and early finding in patients in the pediatric cardiac intensive care unit. J. Pediatr. 2018; 195: 206–212. pmid:29395177
  21. 21. Mody K, Kaur S, Mauer EA, Gerber LM, Greenwald BM, Silver G, et al. Benzodiazepines and development of delirium in critically ill children: estimating the causal effect. Crit Care Med. 2018; 46(9):1486–1491. pmid:29727363
  22. 22. Ricardo Ramirez C, Álvarez Gómez ML, Agudelo Vélez CA, Zuluaga Penagos S, Consuegra Peña RA. Clinical characteristics, prevalence, and factors related to delirium in children of 5 to 14 years of age admitted to intensive care. Med Intensiva. 2019; 43(3):147–155. pmid:29530328
  23. 23. Patel AK, Biagas KV, Clarke EC, Gerber LM, Mauer E, Silver G, et al. Delirium in children after cardiac bypass surgery. Pediatr Crit Care Med. 2017;18(2): 165–171. pmid:27977539
  24. 24. Traube C, Silver G, Reeder RW, Doyle H, Hegel E, Wolfe HA, et al. Delirium in critically ill children: an international point prevalence study. Crit. Care Med. 2017; 45(4): 584–590. pmid:28079605
  25. 25. Ge XH, Wei WR, Feng TN, Xu LL, Hu YQ, Yuan CR. Analysis of risk factor for pediatric intensive care unit delirium in children: a case-control study. Am J Transl Res. 2021; 13(8): 9143–9151. pmid:34540029
  26. 26. Yontem A, Yildizdas D, Horoz OO,Ekinci F, Misirlioglu M. Frequency and causes of delirium in pediatric intensive care unit: a prospective observational study. Indian J Crit Care Med. 2021; 25(6): 715–719. pmid:34316155
  27. 27. Staveski SL, Pickler RH, Khoury PR,Ollberding NJ, Donnellan AL, Mauney JA, et al. Prevalence of ICU delirium in postoperative pediatric cardiac surgery patients. Pediatr Crit Care Med. 2021; 22(1): 68–78. pmid:33065733
  28. 28. Holly C, Porter S, Echevarria M, Dreker M, Ruzehaji S. Recognizing delirium in hospitalized children: a systematic review of the evidence on risk factors and characteristics. Am J Nurs. 2018; 118: 24–36. pmid:29543606
  29. 29. Dervan LA, Di Gennaro JL, Farris RWD, Watson RS. et al. Delirium in a tertiary PICU: risk factors and outcomes. Pediatr Crit Care Med. 2020; 21(1): 21–32. pmid:31568239
  30. 30. Madden K, Callif CG, Tasker RC. Exposure to anticholinergic medications in pediatric severe sepsis and feasibility of delirium screening. J Pediatr Intensive Care. 2020; 9(4):271–276. pmid:33133743
  31. 31. Madden K, Hussain K, Tasker RC. Anticholinergic medication burden in pediatric prolonged critical illness: a potentially modifiable risk factor for delirium. Pediatr Crit Care Med. 2018; 19(10): 917–924. pmid:30284995
  32. 32. Flaigle MC, Ascenzi J, Kudchadkar SR. Identifying barriers to delirium screening and prevention in the pediatric ICU: evaluation of PICU staff knowledge. J Pediatr Nurs. 2016; 31(1): 81–84. pmid:26362671
  33. 33. Norman SL, Taha AA. Delirium knowledge, self-confidence, and attitude in pediatric intensive care nurses. J Pediatr Nurs. 2019; 46: 6–11. pmid:30802805